Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OST was a leading global supplier of superconducting wire for MRI, NMR, and high-energy physics applications; widely utilized in commercial imaging and scientific projects until acquisition by Bruker/BEST in 2016. Oxford Instruments Superconducting Wire was a world-leading supplier of superconducting wire primarily used in medical imaging (MRI/NMR) and large scientific research magnets. Its market extended globally, servicing major OEMs and big science collaborations. In November 2016, it was sold for $17.5 million to Bruker Corporation (BEST), where it continues operations as part of the world's largest provider of low-temperature superconductors. It is not a drug developer, but a critical contributor to healthcare and scientific instrumentation through device components.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oxford Instruments Superconducting Wire.